Trastuzumab emtansine trials for Breast cancer

All Trastuzumab emtansine trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Trastuzumab emtansine for Breast cancer

• Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
  NCT06348134 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 4 locations
• Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
  NCT06324357 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 105 locations
• DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer
  NCT06313086 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
  NCT04680442 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 8 locations

Common questions

How many trials study Trastuzumab emtansine for Breast cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.